Cardiometabolic Health Congress (CMHC) | VuMedi

Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress (CMHC)

The global epidemic of metabolic syndrome, a constellation of cardiometabolic risk factors, and that of obesity, type 2 diabetes, atherosclerosis, chronic kidney disease, cardiovascular disease, and NAFLD/NASH, have become the modern-day health hazard across the world. Lifestyle factors, including a lack of physical activity and proper nutrition, as well as ...
read more ↘ smoking, can further exacerbate the impacts of cardiometabolic risk or disease, which is showing no signs of slowing down. Overall, the numbers are particularly striking. There are more than 463 million adults living with diabetes worldwide, and the number is expected to rise to more than 700 million by 2045.1 Furthermore, 232 million have undiagnosed diabetes with an additional 374 million having prediabetes.1 The increasing prevalence of overweight and obesity (now estimated to affect 2 billion adults, or nearly 30% of the world population), high cholesterol (>40% of the world’s population), and hypertension (>1 billion), together with type 2 diabetes (T2D), are some of the major drivers of morbidity and mortality worldwide.2-4 They affect multiple organ systems, including the heart, liver, and kidneys, spanning several disease domains and outcomes.

Although clinicians are learning more about the interconnections between these conditions and risk factors, the application of these principles to patient care remains in its infancy. As these diseases and risk factors exist in a continuum, they cannot be treated in silos, which is unfortunately what tends to happen in clinical practice. The Cardiometabolic Health Congress (CMHC) has been at the forefront of looking at the whole spectrum of cardiometabolic disease, including obesity, diabetes, lipids, hypertension, cardio-renal disease, and practical ways to address them. Through our live conferences and extensive online education platforms, we strive to synthesize and translate the latest cutting-edge medical research into practical clinical strategies for preventing, delaying, diagnosing, treating, and managing the whole spectrum of cardiometabolic disorders. The goal is to provide the medical community with evidence-based interventions that they can apply immediately in clinical practice to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.
↖ read less

COVID-19

Cardiometabolic Health Congress (CMHC)

COVID-19 Burden in Racial/Ethnic Minorities: What Variables Make African Americans More Vulnerable to COVID-19?

FEATURING Keith Ferdinand

59 views
May 21, 2021

Cardiometabolic Health Congress (CMHC)

COVID-19 Roadblocks and Reflections (Panel Discussion): How Have Clinical, Behavioral and Cultural Factors Contributed to Increased Burden in Racial/Ethnic Minorities?

FEATURING Keith Ferdinand, Kevin M. Alexander, Yvonne Commodore-Mensah, Takeisha C. Davis, Alanna Morris, Pam Taub

3 views
May 21, 2021

Cardiometabolic Health Congress (CMHC)

Influenza Epidemiology: What Is the Prevalence and Disease Burden per Season in the US? How Does the Virus Shift and Drift & How Does That Influence the Vaccine and Transmission? How Many Vaccines Are Out There & Who Should Get One?

FEATURING Gregory A. Poland

963 views
June 1, 2020
6

Cardiometabolic Health Congress (CMHC)

How Do Age-Related Biologic Changes Influence the Clinical Presentations of Influenza? What Are the Consequences of Influenza on the Cardiovascular System? Is Flu Vaccination Protective Against AMI, Cardiac Death and Stroke?

FEATURING Stefan Gravenstein

321 views
June 1, 2020

Cardiometabolic Health Congress (CMHC)

Influenza Treatment: What Antivirals Are Available & Which Are Recommended for Use? How Safe and Efficient Is the Use of Oseltamivir and Baloxavir? Are Immunoglobulins and Polymerase Inhibitors Effective in Treatment?

FEATURING Michael G. Ison

18 views
June 1, 2020

Cardiometabolic Health Congress (CMHC)

Would You Test Patients With Influenza Symptoms & How Would You Treat? When Should You Start the Treatment? Why You Should Get Vaccinated?

FEATURING Michael G. Ison

773 views
June 1, 2020
2

Cardiometabolic Health Congress (CMHC)

COVID-19 & Obesity: Is There any Evidence that Obese Patients Have a Higher Risk of Infection? Could Obesity Be a Factor in the Death Toll in the Younger Population? Should SGLT2 Inhibitors and Other Therapies Be Discontinued Upon Hospitalization?

FEATURING Robert Eckel

1,285 views
May 22, 2020
10

Cardiometabolic Health Congress (CMHC)

COVID-19 & Diabetes: Is Diabetes an Independent Risk Factor for Infection? Should There Be Any Concern About Current Diabetes Therapies or Modifying the Therapies in Infected Patients?

FEATURING Anne Louise Peters

47 views
May 22, 2020

Cardiometabolic Health Congress (CMHC)

Should Troponin Be Checked in All Patients Who Are Admitted to the Hospital with COVID-19? Is There any Evidence for Changing Statin Therapy in Infected Patients & Could Rosuvastatin Be Beneficial?

FEATURING Christie Ballantyne

2,558 views
May 22, 2020
6

Cardiometabolic Health Congress (CMHC)

Does COVID-19 Have a Predilection for CV Disease? Is Having High ACE2 Levels a Good Thing? Is There Enough Evidence to Support Treatment with Hydroxychloroquine?

FEATURING Clyde Yancy

35 views
May 22, 2020

Cardiometabolic Health Congress (CMHC)

COVID-19: Should ACE inhibitors and Angiotensin Receptor Blockers Be Withdrawn? Have They Been Demonstrated to be Directly Related to Damage to the CV or Pulmonary Systems in COVID-19 Patients?

FEATURING Keith Ferdinand

2,896 views
May 22, 2020
13